Frequency of Chlamydia trachomatis in endocervical samples of women referred toGynecology Hospital in Qazvin-Iran, by PCR-based assay

Background: Chlamydia trachomatis (C. trachomatis) is the most common bacterial sexually transmitted infection (STI). Although most genital C. trachomatis infection remain asymptomatic but infection with this bacteria is leading cause of complications e.g pelvic inflammatory infection (PID) tubal factor infertility and abortion. Objectives: The objective of this study was to estimate the Frequency of Chlamydia trachomatis infection among symptomatic and asymptomatic women, by PCR-based assay. Methods: This was a cross-sectional study conducted over the period from, May 2012 to February 2013.A total of 240 non duplicate endocervical samples were taken from married women endocervical swabs were collected from women referred to Qazvin Kowsar Gynecology Hospital by training midwife. The specimens were tested for C. trachomatis by PCR-based assay for pha gene.Results: Out of 240 participants women 184 (76.7%) were symptomatic and 56 (23.3%) were asymptomatic cases). The mean age of cases was 37.1±.0.9 years. Twenty (8.3%) of 240 samples were diagnosed as Chlamydia positive according to PCR results. The prevalence of asymptomatic C. trachomatis infections was 6(10.7%), while14 (7.6%) symptomatic cases were infected. The chi square test was not show a significant relationship between positive PCR test result and vaginosis, abortion , infertility, premature birth, low birth weight below 2.5kg. Conclusion: The results of this study showed high prevalence of C. trachomatis infection among in both symptomatic and asymptomatic women. Therefore, a screening test for C. trachomatis infection is recommended for all women who refer to genitourinary medicine clinic. Screening programs are important for cost effectiveness calculations in complication of C. trachomatis infections especially in asymptomatic cases. Keywords: Chlamydia trachomatis, PCR, endocervical sample, Iran

[1]  Elizabeth A Torrone,et al.  Prevalence of Chlamydia trachomatis Genital Infection Among Persons Aged 14–39 Years — United States, 2007–2012 , 2014, MMWR. Morbidity and mortality weekly report.

[2]  L. Abu-Raddad,et al.  Prevalence of Chlamydia trachomatis infection in the general population of women in Qatar , 2013, Sexually Transmitted Infections.

[3]  T. Read,et al.  A Multiplexed Microfluidic PCR Assay for Sensitive and Specific Point-of-Care Detection of Chlamydia trachomatis , 2012, PloS one.

[4]  A. Znazen,et al.  Chlamydia trachomatis genovar distribution in clinical urogenital specimens from Tunisian patients: high prevalence of C. trachomatis genovar E and mixed infections , 2012, BMC Infectious Diseases.

[5]  C. Cuffini,et al.  Molecular Epidemiology of Genital Chlamydia T rachomatis Infection in Asymptomatic Adolescent-Young People , 2012 .

[6]  V. Vullo,et al.  Epidemiology of Chlamydia trachomatis endocervical infection in a previously unscreened population in Rome, Italy, 2000 to 2009. , 2012, Euro surveillance : bulletin Europeen sur les maladies transmissibles = European communicable disease bulletin.

[7]  E. Hiltunen-Back,et al.  Chlamydia trachomatis Genotypes and the Swedish New Variant among Urogenital Chlamydia trachomatis Strains in Finland , 2011, Infectious diseases in obstetrics and gynecology.

[8]  S. Morré,et al.  Genotyping of Chlamydia trachomatis strains from culture and clinical samples using an ompA-based DNA microarray assay. , 2011, Molecular and Cellular Probes.

[9]  Bin Yang,et al.  The prevalence and distribution of Chlamydia trachomatis genotypes among sexually transmitted disease clinic patients in Guangzhou, China, 2005-2008. , 2010, Japanese journal of infectious diseases.

[10]  W. Mcfarland,et al.  HIV/AIDS in the Middle East and North Africa: new study methods, results, and implications for prevention and care , 2010, AIDS.

[11]  David P. Wilson,et al.  Characterizing the HIV/AIDS Epidemic in the Middle East and North Africa: Time for Strategic Action , 2010 .

[12]  M. Postma,et al.  Epidemiology of Chlamydia trachomatis infection in women and the cost-effectiveness of screening. , 2010, Human reproduction update.

[13]  R. Stephens,et al.  Attachment and Entry of Chlamydia Have Distinct Requirements for Host Protein Disulfide Isomerase , 2009, PLoS pathogens.

[14]  E. Sakurai,et al.  Prevalence and risk factors for Chlamydia trachomatis infection in adolescent females and young women in central Brazil , 2006, European Journal of Clinical Microbiology and Infectious Diseases.

[15]  Mellisa L. Theodore,et al.  Comparison of Three Nucleic Acid Amplification Tests for Detection of Chlamydia trachomatis in Urine Specimens , 2004, Journal of Clinical Microbiology.

[16]  P. Mårdh Tubal factor infertility, with special regard to chlamydial salpingitis , 2004, Current opinion in infectious diseases.

[17]  J. Peipert,et al.  Genital Chlamydial Infections , 2003 .

[18]  J. Paavonen,et al.  The accuracy and efficacy of screening tests for Chlamydia trachomatis: a systematic review. , 2002, Journal of medical microbiology.

[19]  L. Ottosson,et al.  Chlamydia trachomatis PCR (Cobas Amplicor) in women: endocervical specimen transported in a specimen of urine versus endocervical and urethral specimens in 2-SP medium versus urine specimen only , 2000, International journal of STD & AIDS.

[20]  E. Baron,et al.  Chlamydia and Chlamydophila. , 2006 .

[21]  H. Goudarzi,et al.  Detection of Chlamydia trachomatis from Urine Specimens by PCR in Women with Cervicitis , 2005 .